Navigation Links
Iomai CEO to Speak at Acumen BioFin Rodman & Renshaw Annual Healthcare Conference on Monday, Nov. 5
Date:11/2/2007

GAITHERSBURG, Md., Nov. 2 /PRNewswire-FirstCall/ -- Iomai Corporation (Nasdaq: IOMI) today announced that Stanley C. Erck, the company's president and chief executive officer, will present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference in New York City on Monday, Nov. 5. Mr. Erck's presentation will begin at 9:10 a.m. Eastern Time in the Kennedy I Room of the New York Palace Hotel.

Mr. Erck's presentation will focus on Iomai's portfolio of patch-based needle-free vaccines and immunostimulants, including its plans to move into Phase 3 trials for its travelers' diarrhea vaccine and the initiation of a Phase 1/2 trial of Iomai's dose-sparing adjuvant patch for use with a pandemic influenza vaccine.

To access the live audio webcast or the subsequent archived recording, log on to the Investor Relations section on the Overview page of the Iomai website at http://www.iomai.com. Please connect to Iomai's website several minutes prior to the start of the live webcast to ensure adequate time for any software downloads that may be necessary.

ABOUT IOMAI CORPORATION

Iomai Corporation discovers and develops vaccines and immune system stimulants, delivered via a novel, needle-free technology called transcutaneous immunization (TCI). TCI, discovered by researchers at the Walter Reed Army Institute of Research, taps into the unique benefits of a major group of antigen-presenting cells found in the outer layers of the skin (Langerhans cells) to generate an enhanced immune response. Iomai is leveraging TCI to enhance the efficacy of existing vaccines, develop new vaccines that are viable only through transcutaneous administration and expand
'/>"/>

SOURCE Iomai Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Iomai to Announce Results From Phase 1 Influenza Trial and Host Webcast Tomorrow
2. Iomai Dose-Ranging Trial Demonstrates Needle-Free Patch Vaccine for Travelers Diarrhea Stimulates Immune Response Even at Low Doses
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
5. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
6. Micromet, Inc. to Present at the 3rd Annual C.E. Unterberg, Towbin Emerging Growth Conference
7. Neurologix to Present at the Third Annual C.E. Unterberg Towbin Emerging Growth Conference
8. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
9. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
10. MaxCyte and Medinet to Present at the 13th Annual Meeting of the International Society for Cellular Therapy (ISCT) in Sydney, Australia
11. ConjuChem Biotechnologies Reports PC-DAC:Exendin-4 Albumin Conjugate Data Presented at American Diabetes Association Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... /PRNewswire/ - Anything Technologies Media, Inc. (OTC:EXMT) has announced ... Solutions (FIGS), www.frontiergarden.com has been announced ... Manager for a My Compassion originated medical cannabis ... in Alaska.  The project will be funded through ... Partners. The first phase of the project, is ...
(Date:7/30/2015)... Sciences, Inc. (NASDAQ: ALIM ) (Alimera), a pharmaceutical ... of prescription ophthalmic pharmaceuticals, today announced that it will ... after the market close on Monday, August 10, 2015. ... day at 4:30 p.m. ET. ... Rick Eiswirth , Chief Operating Officer and Chief ...
(Date:7/30/2015)... YORK, England , July 30, 2015 /PRNewswire/ ... Regenix" or "The Group") the regenerative medical devices ... position within the post-acute wound care market as ... approval for DermaPure® under Medicare administrator, First Coast ... Florida , Puerto ...
Breaking Medicine Technology:Frontier Indoor Garden Solutions announced as Horticultural Supplier and Project Manager for Alaskan Tribal Medical Marijuana Grow Facility 2Frontier Indoor Garden Solutions announced as Horticultural Supplier and Project Manager for Alaskan Tribal Medical Marijuana Grow Facility 3Alimera Sciences To Release Second Quarter Fiscal Year 2015 Financial Results 2Tissue Regenix Group plc: First Coast Service Options Inc. Approves Medicare Coverage for DermaPure 2Tissue Regenix Group plc: First Coast Service Options Inc. Approves Medicare Coverage for DermaPure 3
... 25, 2012  Soligenix, Inc. (OTCBB: SNGX) (Soligenix or ... today further progress in the development of ThermoVax™, ... based on additional characterization of the stability of ... temperatures in excess of three months. These studies ...
... As part of its digital check-in process, Phreesia offers ... Autism in Toddlers (M-CHAT), a screening tool to assess risk ... 30 months old.* The American Academy of Pediatrics (AAP) recommends ... months of age, in addition to broad developmental screening at ...
Cached Medicine Technology:Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability 2Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability 3Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability 4Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability 5Phreesia identifies over 26% of patients who require additional autism evaluation 2Phreesia identifies over 26% of patients who require additional autism evaluation 3
(Date:7/30/2015)... ... July 30, 2015 , ... The Beryl Institute announces its ... partnership with Patient Experience Institute, these offerings reinforce the commitment to help frame ... and throughout the experience movement, and provide information and research to support expanded ...
(Date:7/30/2015)... , ... July 30, 2015 , ... ... the ‘Mary Jo Lawyer-Spano Mesothelioma Patient Registry Act of 2015’. The bill ... Chris Collins (R-NY), Peter King (R-NY), Betty McCollum (D-MN), Joe Kennedy (D-MA), and ...
(Date:7/30/2015)... ... July 30, 2015 , ... Boston ... the annual All-Stars Summit. Google Partners is the platform for search marketing agencies ... full support and tools necessary to run successful search marketing campaigns. Google Partners ...
(Date:7/30/2015)... ... July 30, 2015 , ... Ocean Hills Recovery has officially been accredited ... “no recommendations.” No recommendations means CARF found no areas in the OHR program that ... than 3% of all facilities receive. In addition, Ocean Hills was granted the maximum ...
(Date:7/30/2015)... New York, NY (PRWEB) , ... July 30, ... ... of Medicine at Mount Sinai Earns National Cancer Institute Designation , The Tisch ... been named a National Cancer Institute (NCI)-designated cancer center. TCI joins an elite ...
Breaking Medicine News(10 mins):Health News:The Beryl Institute Opens Applications for 2015 Patient Experience Grant and Scholar Programs 2Health News:The Beryl Institute Opens Applications for 2015 Patient Experience Grant and Scholar Programs 3Health News:Bill to Create Patient Registry for Deadly Cancer Introduced in Congress 2Health News:Boston Web Marketing Attends Google Partners All-Stars Summit 2Health News:Ocean Hills Recovery Receives Accreditation from CARF International 2Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 2Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 3Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 4Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 5Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 6
... from the dreaded flu or influenza is just a step ... 2003 released// the FluMist, a popular influenza virus vaccine has ... has been approved by the Food and Drug Administration, ... or by its clinical name CAIV-T (cold adapted influenza vaccine-trivalent) ...
... young adults was associated with a higher risk ... in Circulation: Journal of the American Heart Association. ... average age 26.5, those with hypertension or prehypertension ... heart structure associated with increased cardiovascular risk: higher ...
... study published in the journal CANCER, finds that the risk ... However, it does not necessarily mean that all obese men// ... reveals that higher body mass index (BMI) and weight gain ... prostate cancer. However, no such association was found between BMI ...
... going in for homeopathic treatment in India and in ... shift, said doctors at a homeopathic conference here. ... following homeopathy, even for cancer treatment at early stages. ... even after receiving chemotherapy treatment, many cancer patients now ...
... campaign is set to take off in Britain amidst bouquets ... food manufacturing//, will seek to realize the goal of providing ... in each serving. ,The GDA campaign has the ... along with well known super markets - Tesco, Somerfield and ...
... of Gardasil vaccine is a boon for the kith and ... ,This vaccine is currently available in 33 countries all ... & Dohme. This vaccine was formed by Professor Ian Frazer, ... Cancer Research (CICR), Australia who in all likelihood could be ...
Cached Medicine News:Health News:Hypertension, Prehypertension in Youngsters Linked With Heart Enlargement 2Health News:Hypertension, Prehypertension in Youngsters Linked With Heart Enlargement 3Health News:The Risk of Death from Prostate Cancer More in Obese Men 2Health News:Homeopathy can Cure Many Chronic Diseases 2
Shake 'n' Stack Oven - New Model (includes 10 bottle capacity rotisserie, adjustable feet, drip tray, manual PLUS Shaker Platform)...
Inquire...
... Interior Dimensions (WxDxH): 31.1 x 13.6 x ... x 22.4 x 20.5 cm, Capacity: 4 ... 300 x 35 mm bottles, 4 - ... - 240 x 80 mm bottle, Power ...
... The Minifold I system consists of four ... vacuum plenum, and metal clamping plate (see diagram). ... configurations for producing spots, dots, or slots (see ... be purchased as an accessory plate in conjunction ...
Medicine Products: